[go: up one dir, main page]

WO2014041528A3 - A composition for the treatment of cutaneous signs of ageing - Google Patents

A composition for the treatment of cutaneous signs of ageing Download PDF

Info

Publication number
WO2014041528A3
WO2014041528A3 PCT/IE2013/000018 IE2013000018W WO2014041528A3 WO 2014041528 A3 WO2014041528 A3 WO 2014041528A3 IE 2013000018 W IE2013000018 W IE 2013000018W WO 2014041528 A3 WO2014041528 A3 WO 2014041528A3
Authority
WO
WIPO (PCT)
Prior art keywords
ageing
composition
treatment
cutaneous signs
collagen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IE2013/000018
Other languages
French (fr)
Other versions
WO2014041528A2 (en
Inventor
Roslain Margaret MARTIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2014041528A2 publication Critical patent/WO2014041528A2/en
Publication of WO2014041528A3 publication Critical patent/WO2014041528A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A composition which can be oral or topical for treating the cutaneous signs of ageing comprising collagen and a combination of Reactive Oxygen Species (ROS) scavengers/antioxidants such Vitamin C, disulfides, tocopherols/tocotrienols, carotenoids and coenzyme Q10 and collagen pre-cursors and use of such compositions for treating cosmetic ageing.
PCT/IE2013/000018 2012-09-14 2013-09-10 A composition Ceased WO2014041528A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IES20120401 2012-09-14
IES2012/0401 2012-09-14

Publications (2)

Publication Number Publication Date
WO2014041528A2 WO2014041528A2 (en) 2014-03-20
WO2014041528A3 true WO2014041528A3 (en) 2014-12-18

Family

ID=50278796

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IE2013/000018 Ceased WO2014041528A2 (en) 2012-09-14 2013-09-10 A composition

Country Status (1)

Country Link
WO (1) WO2014041528A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3160440B1 (en) * 2014-06-30 2021-10-27 NUTRICOS Technologies Combination products and cosmetic compositions for controlling skin disorders and skin aging that affect keratinocytes and/or fibroblasts and the dermis
GB201511255D0 (en) * 2015-06-26 2015-08-12 Colltec Ltd Formulation
JP6739472B2 (en) * 2018-05-30 2020-08-12 株式会社粧薬研究所 Agent containing horse placenta extract as active ingredient
WO2022124386A1 (en) * 2020-12-07 2022-06-16 L' Oreal Composition comprising ascorbic acid and cyclic amino acid
JP2022090263A (en) * 2020-12-07 2022-06-17 ロレアル Compositions Containing Ascorbic Acid and Cyclic Amino Acids
CN113101237A (en) * 2021-04-16 2021-07-13 东晟源研究院(广州)有限公司 Polyglutamic acid with anti-wrinkle effect and application of polyglutamic acid in cosmetics
CN116138375A (en) * 2022-11-01 2023-05-23 广州迈菲科技有限公司 Beverage based on deep sea fish dissolution and collagen extraction and production method thereof
JP2025536779A (en) * 2022-11-24 2025-11-07 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ Use of the composition for giving the skin a vibrant glow

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19831798A1 (en) * 1998-07-15 2000-01-27 Mandorlo Investment Gmbh Luxem Microcirculation improving skin and tissue care or treatment composition, containing salts, aminoacids and peroxide, used as cosmetic, medicament or nutrient supplement
WO2000008061A1 (en) * 1998-08-05 2000-02-17 Jasper Ltd. Liability Co. Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions
WO2001017484A2 (en) * 1999-09-07 2001-03-15 D.T.R. Dermal Therapy Research Inc. Topical urea composition
WO2002026207A2 (en) * 2000-09-28 2002-04-04 Provincia Italiana Della Congregazione Dei Figli Dell'immacolata Concezione - Istituto Dermopatico Dell'immacolata Cosmetic formulation
US20040265268A1 (en) * 2001-08-18 2004-12-30 Deepak Jain Compositions and methods for skin rejuvenation and repair
US20050048008A1 (en) * 2003-08-29 2005-03-03 Bioderm Research Antiaging Cosmetic Delivery Systems
US20060182794A1 (en) * 2005-02-14 2006-08-17 Pankaj Modi Stabilized compositions for topical administration and methods of making same
EP1932514A1 (en) * 2005-10-05 2008-06-18 Ezaki Glico Co., Ltd. Pharmaceutical preparation for external application to skin comprising phosphorylated sugar
WO2009008397A1 (en) * 2007-07-06 2009-01-15 Fujifilm Corporation Cosmetic composition
EP2033689A1 (en) * 2007-08-22 2009-03-11 Italfarmacia S.r.l. Injectable dermatological composition for treatment of the wrinkles
EP2404642A2 (en) * 2010-07-09 2012-01-11 The Direct Marketing Company S.p.A. (brevemente DMC S.p.A.) Process for preparing a cosmetic composition having an immediate lifting effect
WO2012014417A1 (en) * 2010-07-28 2012-02-02 株式会社 資生堂 Use of plant or like for improving pores, method for improving pores and oral preparation for improving pores
WO2012035904A1 (en) * 2010-09-13 2012-03-22 株式会社資生堂 Agent for promoting hyaluronic acid production
EP2727580A1 (en) * 2011-06-28 2014-05-07 Fujifilm Corporation Astaxanthin-containing composition, method for manufacturing same, and cosmetic

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19831798A1 (en) * 1998-07-15 2000-01-27 Mandorlo Investment Gmbh Luxem Microcirculation improving skin and tissue care or treatment composition, containing salts, aminoacids and peroxide, used as cosmetic, medicament or nutrient supplement
WO2000008061A1 (en) * 1998-08-05 2000-02-17 Jasper Ltd. Liability Co. Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions
WO2001017484A2 (en) * 1999-09-07 2001-03-15 D.T.R. Dermal Therapy Research Inc. Topical urea composition
WO2002026207A2 (en) * 2000-09-28 2002-04-04 Provincia Italiana Della Congregazione Dei Figli Dell'immacolata Concezione - Istituto Dermopatico Dell'immacolata Cosmetic formulation
US20040265268A1 (en) * 2001-08-18 2004-12-30 Deepak Jain Compositions and methods for skin rejuvenation and repair
US20050048008A1 (en) * 2003-08-29 2005-03-03 Bioderm Research Antiaging Cosmetic Delivery Systems
US20060182794A1 (en) * 2005-02-14 2006-08-17 Pankaj Modi Stabilized compositions for topical administration and methods of making same
EP1932514A1 (en) * 2005-10-05 2008-06-18 Ezaki Glico Co., Ltd. Pharmaceutical preparation for external application to skin comprising phosphorylated sugar
WO2009008397A1 (en) * 2007-07-06 2009-01-15 Fujifilm Corporation Cosmetic composition
EP2033689A1 (en) * 2007-08-22 2009-03-11 Italfarmacia S.r.l. Injectable dermatological composition for treatment of the wrinkles
EP2404642A2 (en) * 2010-07-09 2012-01-11 The Direct Marketing Company S.p.A. (brevemente DMC S.p.A.) Process for preparing a cosmetic composition having an immediate lifting effect
WO2012014417A1 (en) * 2010-07-28 2012-02-02 株式会社 資生堂 Use of plant or like for improving pores, method for improving pores and oral preparation for improving pores
WO2012035904A1 (en) * 2010-09-13 2012-03-22 株式会社資生堂 Agent for promoting hyaluronic acid production
EP2727580A1 (en) * 2011-06-28 2014-05-07 Fujifilm Corporation Astaxanthin-containing composition, method for manufacturing same, and cosmetic

Also Published As

Publication number Publication date
WO2014041528A2 (en) 2014-03-20

Similar Documents

Publication Publication Date Title
WO2014041528A3 (en) A composition for the treatment of cutaneous signs of ageing
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
EP3258942A4 (en) Cosmetic and topical compositions comprising cannabigerol
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
WO2010027792A8 (en) Treatment of sweating and hyperhidrosis
WO2013103701A3 (en) Personal care compositions containing end-functionalized ionic silicone
WO2010119423A3 (en) Cosmetic compositions comprising oridonin and new cosmetic uses
WO2012050745A3 (en) Compositions containing zinc pca and anogeissus extract
WO2013078259A3 (en) Oil compositions and methods for increasing hair growth and/or preventing hair loss
WO2013024282A3 (en) Inhibitor or down- regulator of the expression of one or both of tbk1 ikk-epsilon for use in the treatment of pi3kinase dependent cancer
WO2014066916A3 (en) Compositions and methods for safe treatment of rhinitis
EP3038474A4 (en) Nutraceutical combination for prevention and treatment of type 2 diabetes
WO2010072787A3 (en) A composition comprising a retinoid and method of treating skin conditions
IL234816A0 (en) Semi-solid topical composition which contains pirfenidone and modified diallyl disulphide oxide (m-ddo) for eliminating or preventing acne
WO2018094023A3 (en) Cyclic dipeptides and wound healing
NZ607997A (en) Fungicidal bactericidal and/or antioxidant treatment of foodstuffs via application of formulations comprising an essential oil and a dialkylene glycol
WO2012024399A3 (en) Compositions comprising paulownin and/or paulownia extracts and uses thereof
WO2012001246A3 (en) Use of a peptidic pea extract as an active antioxidant in a cosmetic composition
CA2799127C (en) Compositions and methods for treating traumatic brain injury
EP3006434A4 (en) Novel compound derived from plant of genus quamoclit and composition containing same as active ingredient for preventing or treating diabetes
WO2011130692A3 (en) Androgen induced oxidative stress inhibitors
WO2014030117A3 (en) Cosmetic use of the essential oil of laserpitium siler l. against the signs of aging of the skin and as a skin antioxidant
WO2018042189A3 (en) Compounds and compositions for use
BR112012003643B8 (en) antibacterial food composition, uses of a composition and kit
WO2014001729A3 (en) Compositions for topical application including a natural plant extract

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13776582

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 13776582

Country of ref document: EP

Kind code of ref document: A2